Insider Buy/Sell Details for the Healthcare Sector — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1953)
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
207
Price
$199.96
Total Value
$41.39K
Shares Held After
41,462
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
100
Price
$199.00
Total Value
$19.90K
Shares Held After
41,669
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
100
Price
$197.70
Total Value
$19.77K
Shares Held After
41,769
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
920
Price
$266.56
Total Value
$245.23K
Shares Held After
1,475,253
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,439
Price
$265.59
Total Value
$647.77K
Shares Held After
1,476,173
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
8,798
Price
$264.85
Total Value
$2.33M
Shares Held After
1,478,612
% of Holdings
0.6%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,043
Price
$263.70
Total Value
$538.74K
Shares Held After
1,487,410
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,380
Price
$262.44
Total Value
$624.62K
Shares Held After
1,489,453
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,962
Price
$261.41
Total Value
$774.29K
Shares Held After
1,491,833
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
3,128
Price
$260.49
Total Value
$814.80K
Shares Held After
1,494,795
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
1,377
Price
$259.87
Total Value
$357.84K
Shares Held After
1,497,923
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
470
Price
$258.38
Total Value
$121.44K
Shares Held After
1,499,300
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
483
Price
$257.31
Total Value
$124.28K
Shares Held After
1,499,770
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,700
Price
$266.42
Total Value
$452.92K
Shares Held After
1,403,155
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
6,000
Price
$265.16
Total Value
$1.59M
Shares Held After
1,404,855
% of Holdings
0.4%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
4,852
Price
$264.64
Total Value
$1.28M
Shares Held After
1,410,855
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,248
Price
$263.58
Total Value
$592.53K
Shares Held After
1,415,707
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,938
Price
$262.35
Total Value
$508.43K
Shares Held After
1,417,955
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,931
Price
$261.41
Total Value
$766.20K
Shares Held After
1,419,893
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,667
Price
$260.37
Total Value
$954.76K
Shares Held After
1,422,824
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
668
Price
$259.61
Total Value
$173.42K
Shares Held After
1,426,491
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
589
Price
$258.54
Total Value
$152.28K
Shares Held After
1,427,159
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
407
Price
$257.32
Total Value
$104.73K
Shares Held After
1,427,748
% of Holdings
0.0%
HENRY SCHEIN INC (HSIC)
MLOTEK MARK E — EVP, Chief Strategic Officer
Shares
1,825
Price
$80.81
Total Value
$147.48K
Shares Held After
80,554
% of Holdings
2.2%
HENRY SCHEIN INC (HSIC)
MLOTEK MARK E — EVP, Chief Strategic Officer
Shares
4,100
Price
$80.80
Total Value
$331.26K
Shares Held After
82,379
% of Holdings
4.7%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
14,581
Price
$9.06
Total Value
$132.10K
Shares Held After
660,658
% of Holdings
2.2%
AbbVie Inc. (ABBV)
Purdue David Ryan — SVP, Controller
Shares
5,230
Price
$233.56
Total Value
$1.22M
Shares Held After
2,654
% of Holdings
66.3%
Entrada Therapeutics, Inc. (TRDA)
WENTWORTH KORY JAMES — Chief Financial Officer
Shares
7,988
Price
$12.25
Total Value
$97.89K
Shares Held After
137,987
% of Holdings
5.5%
uniQure N.V. (QURE)
Potts Jeannette — Chief Legal Officer
Shares
3,412
Price
$9.06
Total Value
$30.91K
Shares Held After
138,483
% of Holdings
2.4%
Progyny, Inc. (PGNY)
Swartz Allison — EVP, GC
Shares
599
Price
$17.54
Total Value
$10.51K
Shares Held After
88,941
% of Holdings
0.7%
Erasca, Inc. (ERAS)
Morris Shannon — Chief Medical Officer
Shares
20,000
Price
$15.04
Total Value
$300.76K
Shares Held After
0
% of Holdings
100.0%
Olema Pharmaceuticals, Inc. (OLMA)
Mitchell Shawnte — CHIEF LEGAL OFFICER
Shares
233
Price
$24.69
Total Value
$5.75K
Shares Held After
0
% of Holdings
100.0%
Olema Pharmaceuticals, Inc. (OLMA)
Mitchell Shawnte — CHIEF LEGAL OFFICER
Shares
24,767
Price
$24.25
Total Value
$600.60K
Shares Held After
233
% of Holdings
99.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
30,941
Price
$16.60
Total Value
$513.62K
Shares Held After
579,573
% of Holdings
5.1%
LeonaBio, Inc. (LONA)
Renninger Robert — CHIEF FINANCIAL OFFICER
Shares
906
Price
$5.37
Total Value
$4.87K
Shares Held After
15,851
% of Holdings
5.4%
LeonaBio, Inc. (LONA)
Worthington Mark — GENERAL COUNSEL and CCO
Shares
1,328
Price
$5.37
Total Value
$7.13K
Shares Held After
18,376
% of Holdings
6.7%
Beta Bionics, Inc. (BBNX)
Hopman Mark — Chief Commercial Officer
Shares
353
Price
$11.57
Total Value
$4.08K
Shares Held After
139,133
% of Holdings
0.3%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
2,963
Price
$18.25
Total Value
$54.06K
Shares Held After
145,355
% of Holdings
2.0%
Bicara Therapeutics Inc. (BCAX)
Raben David — Chief Medical Officer
Shares
16,300
Price
$18.52
Total Value
$301.92K
Shares Held After
55,286
% of Holdings
22.8%
LeonaBio, Inc. (LONA)
Litton Mark James — Director
Shares
5,156
Price
$5.37
Total Value
$27.69K
Shares Held After
57,926
% of Holdings
8.2%
Akebia Therapeutics, Inc. (AKBA)
Butler John P. — Director
Shares
69,270
Price
$1.25
Total Value
$86.59K
Shares Held After
3,367,064
% of Holdings
2.1%
LeonaBio, Inc. (LONA)
CHURCH KEVIN — CHIEF SCIENTIFIC OFFICER
Shares
1,359
Price
$5.37
Total Value
$7.30K
Shares Held After
25,178
% of Holdings
5.1%
LeonaBio, Inc. (LONA)
San Martin Javier — CHIEF MEDICAL OFFICER
Shares
1,720
Price
$5.37
Total Value
$9.24K
Shares Held After
15,887
% of Holdings
9.8%
UNITED THERAPEUTICS Corp (UTHR)
KURZWEIL RAY — Director
Shares
4,910
Price
$489.02
Total Value
$2.40M
Shares Held After
12,670
% of Holdings
27.9%
UNITED THERAPEUTICS Corp (UTHR)
Thompson Tommy G — Director
Shares
2,000
Price
$489.42
Total Value
$978.84K
Shares Held After
8,480
% of Holdings
19.1%
UNITED THERAPEUTICS Corp (UTHR)
CAUSEY CHRISTOPHER — Director
Shares
20
Price
$490.17
Total Value
$9.80K
Shares Held After
4,190
% of Holdings
0.5%
HARROW, INC. (HROW)
Opaleye Management Inc. — 10% Owner
Shares
4,263
Price
$39.67
Total Value
$169.12K
Shares Held After
59,428
% of Holdings
6.7%
HARROW, INC. (HROW)
Opaleye Management Inc. — 10% Owner
Shares
134,000
Price
$39.67
Total Value
$5.32M
Shares Held After
3,622,000
% of Holdings
3.6%
RESMED INC (RMD)
FARRELL PETER C — Director
Shares
2,000
Price
$260.22
Total Value
$520.44K
Shares Held After
62,773
% of Holdings
3.1%
FibroBiologics, Inc. (FBLG)
Khoja Hamid — Chief Scientific Officer
Shares
30,000
Price
$0.38
Total Value
$11.40K
Shares Held After
61,250
% of Holdings
49.0%
Showing 1201–1250 of 1953 transactions (page 25 of 40)